Press release
Global Constrained Peptide Drugs Market Analysis and Forecast, 2023-2031
Market Segmentation
Product: BT1718, BT5528, Zilucoplan (RA101495), Rusfertide (PTG-300), PN-943
Peptide Type: Cyclic Peptides, Disulfide-Rich Peptides (DRPs)
Region: North America, Europe, Asia-Pacific
Regional Segmentation
North America U.S. and Canada
Europe U.K., Germany, France, Italy, and Spain
Asia-Pacific Japan
Market Growth Drivers
Enhanced Binding Affinity and Cellular Uptake
Development of Synthetic Constraining Methods
Limitations with Conventional Peptides
Increasing Government and Private Funding
Market Challenges
Increased Competition from Biologics
Risk of Immunogenic Effects and Unsatisfactory ADME Properties
Market Opportunities
Role of Constrained Peptides in Drug Discovery
Various Application in CNS Disease Studies and Anti-Cancer Therapy
Key Companies Profiled
Aileron Therapeutics, Inc, Bicycle Therapeutics, PLC, Polyphor Limited, Protagonist Therapeutics, Inc, Santhera Pharmaceuticals Holding, Union Chimique Belge S.A. (UCB), Pepscan Therapeutics B.V., Pepticom Ltd., PeptiDream, Inc., CPC Scientific Inc., Creative Peptides, Bio-Synthesis Inc
Key Questions Answered in this Report:
What are constrained peptides?
How are constrained peptide drugs developed?
What are the potential indications targeted using constrained peptide drugs?
What are emerging constrained peptide drugs?
How does the pipeline for the global constrained peptide drugs market look like?
What is the market size and future potential of constrained peptide drugs?
What are the major market drivers, challenges, and opportunities in the global constrained peptide drugs market?
What is the mechanism of action of constrained peptides?
What changes in dose administration are being tried the most in pipeline products?
How does the clinical trial landscape look for the global constrained peptide drugs market?
What will be the impact of COVID-19 on this market?
What is the forecast revenue of the global constrained peptide drugs market (by peptide type)?
Which region is expected to contribute to the highest revenue of the global constrained peptide drugs market during the forecast period?
Market Overview
The global constrained peptide drugs market is anticipated to be valued at $60.1 million in 2023 and is expected to reach $10,367.2 million by 2031, witnessing a CAGR of 90.37% during the forecast period 2023-2031. The market growth in revenue is largely fueled by the promise of a novel breakthrough constrained peptide pipeline, which is no longer restricted to receptor targets. Advancements in chemical technologies, the therapeutics success of commercialized synthetic peptides in recent years, and the affordable pricing being realized by these biomolecules in a wide range of diseases are some additional factors attributing to the projected growth in the forecast period.
Competitive Landscape
The global constrained peptide drugs market comprises several companies established in the past decade. The increase in need of unmet clinical need, cost-effective treatment, innovative route of administration, and numerous biological intervention opportunities can be considered as the key factors driving the global constrained peptide drugs market. Analysis of the key strategies incorporated by the players of the global constrained peptide drugs market suggest pipeline constrained peptides as priority product in the portfolio. The companies are tapping the opportunity to incessantly evolve constrained peptides as best-in-class treatments for a wide therapeutic spectrum. In the past four years, key market players in the global constrained peptide drugs market have witnessed nine regulatory and legal activities, nine synergistic activities, 28 clinical developments, two mergers and acquisitions, and 28 funding activities.Please see more details: https://www.marketresearchdirect.com/report/global-constrained-peptide-drugs-market-focus-on-peptide-type-product-and-country-analysis-analysis-and-forecast-2023-2031/
Challenge House, Sherwood Drive, Milton Keynes, MK3 6DP ENGLAND UNITED KINGDOM
Market Research Direct is a single source for premium market research reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Constrained Peptide Drugs Market Analysis and Forecast, 2023-2031 here
News-ID: 2797213 • Views: β¦
More Releases from MarketResearchDirect.com
The Global Small Cell Lung Cancer Market: Prevalence, Treatment, and Market Play β¦
The global market for small cell lung cancer is set to grow in the coming years, driven by the increasing prevalence of the disease. Small cell lung cancer is a sub-type of lung cancer that accounts for less than 20% of cases, and its treatment has proven challenging due to poor survival rates. The median overall survival for patients with small cell lung cancer is just over a year, andβ¦
Nanocellulose: Global Markets
Summary:
The global nanocellulose market totaled $REDACTED in 2021 and $REDACTED in 2022. Growing at a CAGR of REDACTED%, the market is expected to reach $REDACTED in 2027.
Given the current state of ecological consciousness, it is challenging to disregard dangerous emissions from any industrial process or human activity due to their negative effects on the environment. Recently, several academics have expressed concern about the need to replace input materials with less-β¦
Anti-Money Laundering: Global Market Outlook
Summary:
Anti-money laundering (AML) comprises laws, policies, and regulations to safeguard financial frauds and illegal activity. Organizations must comply with these regulations even though compliance led financial institutions do have compliance departments and purchase software solutions. As times are changing, organizations are becoming more adaptive to the AML technologies and the end-user industry is reflecting various important trends shaping how they are being utilized. Increasing stringent regulations and compliance obligations forβ¦
Global Multi-Factor Authentication Market: Trends and Forecast (2022-2027)
Summary:
The demand for MFA, requiring additional proof of identity beyond a simple username and password is gaining widespread acceptance, worldwide. The rising number of identity thefts and breaches, as well as the increased use of IoT/BYOD devices, are driving up demand for MFA. Face recognition, voice analysis and iris recognition are used by organizations to authenticate and verify employees. Post pandemic, there has been a dramatic increase in cyber-based attacksβ¦
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva β¦
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growthβ¦
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis β¦
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehensionβ¦
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
β’ Global Peptide Cancer Drug Market Insight By Region & Indication
β’ Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
β’ Approved Peptide Cancer Drugs: > 30 Drugs
β’ Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
β’ Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
β’ Insight On Peptide Cancer Drugs In Clinical Trials: >β¦
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market β¦
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence ofβ¦
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept β¦
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the globalβ¦
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an establishedβ¦
